When Will Moderna File for FDA Approval for Its COVID Vaccine?

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) recently submitted for full approval by the U.S. Food and Drug Administration (FDA) for their COVID-19 vaccine. Another company should be hot on their heels, though. In this Motley Fool Live video recorded on May 17, healthcare and cannabis bureau chief Corinne Cardina and Motley Fool contributor Keith Speights discuss when Moderna (NASDAQ:MRNA) will file for FDA approval of its rival vaccine.